Moleculin Biotech, Inc. share price logo

Moleculin Biotech, Inc. Share Price

NASDAQ: MBRX

Small Cap

$0.47

-0.01

(-1.50%)

as on

Moleculin Biotech, Inc. Stock Performance

as on October 14, 2025 at 1:29 am IST

  • Day's Low

    Day's High

    $0.46
    $0.5
    downward going graph

    2.13%

    Downside

    6.38%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $0.25
    $3.65
    downward going graph

    46.81%

    Downside

    676.57%

    Upside

    downward going graph

Moleculin Biotech, Inc. share price movements today

Previous Close
$0.47
Open
$0.47
Volume
1.7M
Day's Low - High
$0.46 - $0.5
52 Week Low - High
$0.25 - $3.65

Moleculin Biotech, Inc. Historical Returns

1 Month Return
+ 28.5 %
3 Month Return
-25.81 %
1 Year Return
-80.27 %
3 Year Return
-96.88 %
5 Year Return
-99.36 %

Moleculin Biotech, Inc. Stock Fundamentals & Key Indicators

Check Moleculin Biotech, Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$23.5M

EPS (TTM)

-5.28

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

EBITDA

-25.3M

Revenue (TTM)

-

Profit Margin

0.00%

Return On Equity TTM

158166000.00%

Moleculin Biotech, Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Moleculin Biotech, Inc. with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
Moleculin Biotech, Inc. image
Moleculin Biotech, Inc.
BUY$23.5M-99.36%NA0.00%
Alnylam Pharmaceuticals, Inc. image
Alnylam Pharmaceuticals, Inc.
BUY$60.3B223.08%-505.15-12.96%
Beone Medicines Ltd image
Beone Medicines Ltd
NA$37.8BNANA-3.89%
Vertex Pharmaceuticals Incorporated image
Vertex Pharmaceuticals Incorporated
BUY$104.6B50.07%28.9831.86%
Regeneron Pharmaceuticals, Inc. image
Regeneron Pharmaceuticals, Inc.
BUY$59.8B-7.17%14.2331.37%

Stock Returns calculator for Moleculin Biotech, Inc. Stock including INR - Dollar returns

The Moleculin Biotech, Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

Moleculin Biotech, Inc. investment value today

Current value as on today

₹25,437

Returns

₹74,563

(-74.56%)

Returns from Moleculin Biotech, Inc. Stock

₹80,169 (-80.17%)

Dollar Returns*

₹5,606 (+5.61%)

Analyst Recommendation on Moleculin Biotech, Inc. Stock

Based on 9 analysts

BUY

88.89%

Buy

11.11%

Hold

0.00%

Sell

Based on 9 analysts, 88.89% of analysts recommend a 'BUY' rating for Moleculin Biotech, Inc.. Average target price of $6.67

Moleculin Biotech, Inc. Share Price Target

Get share price movements and forecasts by analysts on Moleculin Biotech, Inc..

What analysts predicted

92.95%UPSIDE

Target Price

$6.67

Current Price

$0.47

Analyzed by

9 Analysts

Target

$6.67

Moleculin Biotech, Inc. target price $6.67, a slight upside of 92.95% compared to current price of $0.47. According to 9 analysts rating.

Moleculin Biotech, Inc. Stock’s Investor Sentiment and Interest

Search interest for Moleculin Biotech, Inc. Stock has increased by 88% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:88% versus previous 30 day period

Moleculin Biotech, Inc. Quarterly Profit & Loss

All numbers in Millions USD

Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Total Revenue
-
-
-
0
0
-
-
0
0
-
Gross Profit
0
0
0
0
0
0
0
0
0
0
Operating Income
-8
-6
-5
-8
-6
-6
-7
-6
-5
-5
EBITDA
-8
-6
-5
-8
-6
-6
-7
-6
-5
-7
Interest Expense
0
-
-
0
0
-
-
-
-
-
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-7
-5
-5
-10
-4
-4
-10
-1
-6
-7
Income Tax Expense
0
0
0
0
0
-
-
-
-
-
Net Income
-7
-5
-5
-10
-4
-4
-10
-1
-6
-7
Net Profit Margin
0.00%
0.00%
0.00%
-2529.31%
-1224.14%
0.00%
0.00%
-1493.65%
-10215.87%
0.00%

Moleculin Biotech, Inc. Annual Profit & Loss

All numbers in Millions USD

Dec 2015
Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Total Revenue
-
-
0
-
-
-
-
-
-
-
Gross Profit
-
0
0
0
0
0
0
0
0
0
Operating Income
0
-3
-8
-15
-17
-19
-22
-30
-29
-26
EBITDA
0
-3
-8
-14
-13
-19
-22
-30
-29
-21
Interest Expense
-
0
-
-
8
0
7
1
-
-
Depreciation
-
-
0
0
0
0
0
0
0
0
Income Before Tax
0
-3
-9
-11
-13
-17
-15
-29
-29
-21
Income Tax Expense
-1
-
1
3
0
-2
-7
-1
-
-
Net Income
0
-3
-9
-11
-13
-17
-15
-29
-29
-21
Net Profit Margin
0.00%
0.00%
-108944.44%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Moleculin Biotech, Inc. Quarterly Cash Flow

All numbers in Millions USD

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Net Income
-5
-5
-10
-4
-4
-10
-1
-6
-7
Operating Cash Flow
-5
-7
-5
-6
-5
-6
-5
-4
-5
Investing Cash Flow
0
0
0
0
0
-
-
-
-
Financing Cash Flow
0
0
4
0
0
4
0
7
5
Change in Cash
-5
-7
-1
-6
-5
-1
-5
3
0

Moleculin Biotech, Inc. Annual Cash Flow

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Net Income
-3
-9
-11
-13
-17
-15
-29
-29
-21
Operating Cash Flow
-3
-7
-12
-17
-17
-18
-27
-24
-23
Investing Cash Flow
0
0
0
0
0
0
0
0
0
Financing Cash Flow
8
10
12
0
22
74
0
4
4
Change in Cash
4
2
0
3
4
55
-27
-19
-19

Global Institutional Holdings in Moleculin Biotech, Inc.

Funds
Holdings
Citigroup Inc
0.28%
XTX Topco Ltd
0.25%
Virtu Financial LLC
0.2%
LPL Financial Corp
0.19%
VERUS CAPITAL PARTNERS, LLC
0.14%
See all

Moleculin Biotech, Inc. News & Key Events

  • img

    Today's Timeline - 21 September

    Mon, 06:06 AM

    -

    Moleculin Biotech's Performance-based Restricted Stock Units under lock-up agreement ending on 22-SEP-2025, restricting stock sales.

Insights on Moleculin Biotech, Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 1 month, MBRX stock has moved up by 30.3%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 62.5% return, outperforming this stock by 142.5%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 148.2% return, outperforming this stock by 245.0%

About Moleculin Biotech, Inc.

moleculin biotech, inc. is a preclinical pharmaceutical company focused on the development of anti-cancer drug candidates, some of which are based on discoveries made at m.d. anderson cancer center. our lead product candidate is annamycin, a phase ii clinical stage anthracycline for the treatment of relapsed or refractory acute myeloid leukemia, more commonly referred to as aml. we also have two pre-clinical small molecule portfolios, one of which is focused on the modulation of hard-to-target tumor cell signaling mechanisms and the recruitment of the patient’s own immune system. the other portfolio targets the metabolism of tumors.
OrganisationMoleculin Biotech, Inc.
Headquarters5300 Memorial Drive, Houston, TX, United States, 77007
IndustryHealth Technology
CEOMr. Walter V. Klemp
E-voting on sharesClick here to vote

Key Management of Moleculin Biotech, Inc.

Name

Title

Dr. Donald H. Picker Ph.D.

Chief Scientific Officer

Dr. Waldemar Priebe Ph.D.

Co-Founder, Founding Scientist & Chairman of Scientific Advisory Board

Dr. John Paul Waymack M.D., Sc.D.

Senior Chief Medical Officer

Mr. Walter V. Klemp

Co-Founder, Chairman, President & CEO

Mr. Jonathan P. Foster CPA

Executive VP & CFO

FAQs

What is Moleculin Biotech, Inc. share price today?

Moleculin Biotech, Inc. share price today is $0.47 as on at the close of the market. Moleculin Biotech, Inc. share today touched a day high of $0.5 and a low of $0.46.

What is the 52 week high and 52 week low for Moleculin Biotech, Inc. share?

Moleculin Biotech, Inc. share touched a 52 week high of $3.65 on and a 52 week low of $0.25 on . Moleculin Biotech, Inc. stock price today i.e. is closed at $0.47,which is 87.12% down from its 52 week high and 88.00% up from its 52 week low.

What is Moleculin Biotech, Inc.'s market capitalisation today?

Moleculin Biotech, Inc. market capitalisation is $0.00T as on .

How to invest in Moleculin Biotech, Inc. Stock (MBRX) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Moleculin Biotech, Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Moleculin Biotech, Inc. Shares that will get you 3.1915 shares as per Moleculin Biotech, Inc. share price of $0.47 per share as on October 14, 2025 at 1:29 am IST.

What is the minimum amount required to buy Moleculin Biotech, Inc. Stock (MBRX) from India?

Indian investors can start investing in Moleculin Biotech, Inc. (MBRX) shares with as little as ₹88.635 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹886.35 in Moleculin Biotech, Inc. stock (as per the Rupee-Dollar exchange rate as on ). Based on Moleculin Biotech, Inc. share’s latest price of $0.47 as on October 14, 2025 at 1:29 am IST, you will get 21.2766 shares of Moleculin Biotech, Inc.. Learn more about fractional shares .

What are the returns that Moleculin Biotech, Inc. has given to Indian investors in the last 5 years?

Moleculin Biotech, Inc. stock has given -99.36% share price returns and 21.02% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?